Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis

被引:28
|
作者
Kishore, Amit [1 ]
Navratilova, Zdenka [1 ]
Kolek, Vitezslav [2 ]
Novosadova, Eva [1 ]
Cepe, Klara [3 ]
du Bois, Roland M. [4 ]
Petrek, Martin [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Pathol Physiol, Hnevotinska 3, Olomouc 77515, Czech Republic
[2] Palacky Univ, Fac Med & Dent, Dept Resp Med & TB, Olomouc, Czech Republic
[3] Palacky Univ, Fac Sci, Olomouc, Czech Republic
[4] Imperial Coll, London, England
关键词
bronchoalveolar lavage; exosomes; microRNA; microvesicles; pulmonary sarcoidosis; ALLERGIC AIRWAY INFLAMMATION; LUNG; EXOSOMES; CELLS; RESPONSES; DISEASE; IMMUNE; MIRNA;
D O I
10.1111/resp.13364
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective MicroRNA (miRNA) are transcriptional regulators implicated in pulmonary sarcoidosis and packaged in extracellular vesicles (EV) during cellular communication. We characterized EV and investigated miRNA expression in bronchoalveolar lavage (BAL) fluid from sarcoidosis patients. Methods EV were characterized for size(s) using dynamic light scattering and transmission electron microscopy (TEM) analysis and protein markers by immunoblotting. Twelve extracellular and 5 cellular miRNA were investigated in BAL from 16 chest X-ray stage-I (CXR-I) and 17 CXR stage-II (CXR-II) sarcoidosis patients. Associations between miRNA and disease characteristics (extrapulmonary involvement, pulmonary function and BAL cell profile) were statistically analysed. Results BAL from sarcoidosis patients contained exosomes and microvesicles (MV) as EV. In these EV, expression of miR-146a (P = 0.007), miR-150 (P = 0.003) and BAL cellular miR-21 (P = 0.01) was increased in CXR-II compared with CXR-I. Other detected EV (miR-21 and miR-26a) and cellular (miR-31, miR-129-3p, miR-146a and miR-452) miRNA were not differentially expressed. The investigated miRNA did not reflect extrapulmonary involvement, but EV miR-146a and miR-150 were negatively correlated with pulmonary function (miR-146a with vital capacity (VC; Spearman's correlation coefficient (r(s)), P = -0.657, 0.007), percent predicted forced expiratory volume in 1 s (FEV1; -0.662, 0.006) and FEV1/forced vital capacity (FVC) ratio (-0.649, 0.008); miR-150 correlated negatively with VC (-0.584, 0.019) and FEV1/FVC ratio (-0.746, 0.001) in CXR-II cases). Conclusion Our data provide evidence that exosomes and microvesicles as extracellular vesicles are present in the bronchoalveolar space of sarcoidosis patients and they differentially express EV miRNA (miR-146a and miR-150), the expression of which correlates negatively with pulmonary function indices. The significance of these findings for disease pathophysiology and clinical course require further investigation.
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 50 条
  • [1] Downregulation of microRNA-30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients
    Liu, Bao
    Jiang, Tingshu
    Hu, Xingang
    Liu, Zhida
    Zhao, Liming
    Liu, Hongmei
    Liu, Zhaihua
    Ma, Lijun
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5799 - 5806
  • [2] Altered Extracellular Vesicle-Derived Protein and microRNA Signatures in Bronchoalveolar Lavage Fluid from Patients with Chronic Obstructive Pulmonary Disease
    Bartel, Sabine
    Wolters, Justina C.
    Noor, Hasnat
    Rafie, Karim
    Fang, Jiahua
    Kirchner, Benedikt
    Nolte-'t Hoen, Esther
    Pfaffl, Michael W.
    Rutgers, Steven
    Timens, Wim
    van den Berge, Maarten
    Hylkema, Machteld N.
    CELLS, 2024, 13 (11)
  • [3] mRNA expression profile of bronchoalveolar lavage fluid cells from patients with idiopathic pulmonary fibrosis and sarcoidosis
    Paplinska-Goryca, Magdalena
    Goryca, Krzysztof
    Misiukiewicz-Stepien, Paulina
    Nejman-Gryz, Patrycja
    Proboszcz, Malgorzata
    Gorska, Katarzyna
    Maskey-Warzechowska, Marta
    Krenke, Rafal
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (09)
  • [4] Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis
    Feng, Haoshen
    Yan, Lili
    Zhao, Yabin
    Li, Zhenhua
    Kang, Jian
    FRONTIERS IN MEDICINE, 2022, 8
  • [5] Endostatin and Cathepsin-V in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
    Naumnik, W.
    Ossolinska, M.
    Plonska, I.
    Chyczewska, E.
    Niklinski, J.
    LUNG CANCER AND AUTOIMMUNE DISORDERS, 2015, 833 : 55 - 61
  • [6] Imaging Changes and Immune-Checkpoint Expression on T Cells in Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
    Kotetsu, Yasuaki
    Yanagihara, Toyoshi
    Suzuki, Kunihiro
    Ando, Hiroyuki
    Eto, Daisuke
    Hata, Kentaro
    Arimura-Omori, Masako
    Yamamoto, Yuzo
    Harada, Eiji
    Hamada, Naoki
    BIOMEDICINES, 2021, 9 (09)
  • [7] sTREM-1 in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis, effect of smoking and inflammation
    Suchankova, M.
    Bucova, M.
    Tibenska, E.
    Demian, J.
    Majer, I
    Novosadova, H.
    Tedlova, E.
    Durmanova, V
    Paulovicova, E.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (12): : 702 - 707
  • [8] Elevated Tenascin-C Levels in Bronchoalveolar Lavage Fluid of Patients with Sarcoidosis
    Fujita, Hanako
    Sakamoto, Noriho
    Ishimatsu, Yuji
    Kakugawa, Tomoyuki
    Nakashima, Shota
    Hara, Shintaro
    Hara, Atsuko
    Mukae, Hiroshi
    Kohno, Shigeru
    LUNG, 2012, 190 (05) : 537 - 543
  • [9] Correlation between the Diagnostic Yield from the Bronchoalveolar Lavage Fluid Analysis and Clinicoradiological Findings in Sarcoidosis
    Akyil, Fatma Tokgoz
    Agca, Meltem
    Ozturk, Hatice
    Sonkaya, Esin
    Erdem, Ipek
    Bulbul, Esra Usta
    Ozbaki, Fatma
    Yildiz, Reyhan
    Bekir, Sumeyye Alparslan
    Sevim, Tulin
    TURKISH THORACIC JOURNAL, 2020, 21 (01): : 21 - 26
  • [10] Kinetics of microRNA Expression in Bronchoalveolar Lavage Fluid Samples
    Brock, Matthias
    Rechsteiner, Thomas
    Kohler, Malcolm
    Franzen, Daniel
    Huber, Lars C.
    LUNG, 2015, 193 (03) : 381 - 385